1. Home
  2. RLAY vs OBK Comparison

RLAY vs OBK Comparison

Compare RLAY & OBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$7.69

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Origin Bancorp Inc.

OBK

Origin Bancorp Inc.

HOLD

Current Price

$37.37

Market Cap

1.2B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
RLAY
OBK
Founded
2015
1912
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.2B
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
RLAY
OBK
Price
$7.69
$37.37
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
8
Target Price
$16.00
$43.00
AVG Volume (30 Days)
2.1M
133.5K
Earning Date
11-06-2025
01-21-2026
Dividend Yield
N/A
1.61%
EPS Growth
N/A
N/A
EPS
N/A
1.91
Revenue
$8,355,000.00
$325,588,000.00
Revenue This Year
$20.47
$13.94
Revenue Next Year
N/A
$6.04
P/E Ratio
N/A
$19.55
Revenue Growth
N/A
N/A
52 Week Low
$1.78
$28.80
52 Week High
$8.36
$41.17

Technical Indicators

Market Signals
Indicator
RLAY
OBK
Relative Strength Index (RSI) 58.73 64.54
Support Level $7.23 $36.13
Resistance Level $8.36 $37.77
Average True Range (ATR) 0.51 0.91
MACD 0.05 0.24
Stochastic Oscillator 69.18 88.52

Price Performance

Historical Comparison
RLAY
OBK

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

About OBK Origin Bancorp Inc.

Origin Bancorp Inc is a financial holding company. The bank provides a broad range of financial services to businesses, municipalities, high-net-worth individuals, and retail clients. The bank principally operates in one business segment, community banking. The bank is engaged in attracting deposits from individuals and businesses and using these deposits and borrowed funds to originate commercial, residential mortgage, construction, and consumer loans. The bank generates the majority of its revenue from interest earned on loans and investments, service charges, and fees on deposit accounts.

Share on Social Networks: